Analytical Data
-
Gene name
ST1
- Application
-
Alternative Names
SDCBP; MDA9; SYCL; TACIP18; Syndecan Binding Protein; Scaffold protein Pbp1; Melanoma differentiation-associated protein 9; Pro-TGF-alpha cytoplasmic domain-interacting 18
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O00560
-
Expression Region
Ser2~Val298
-
Molecular Weight
36kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ST1 recombinant protein has garnered significant attention in the field of biochemistry and molecular biology due to its potential applications in therapeutic and diagnostic processes. The protein, originally identified in specific strains of Streptococcus, plays a crucial role in various biological functions, including immune response modulation and cell signaling pathways. Researchers have focused on ST1 due to its unique structural properties and functional capabilities, which suggest it could serve as a valuable tool in drug development and vaccine formulation. Moreover, the ability to produce ST1 as a recombinant protein allows for high-yield and cost-effective manufacturing, facilitating extensive research into its mechanisms of action. Studies have demonstrated that ST1 interacts with multiple cellular targets, promoting further investigation into its implications for autoimmune diseases and infectious conditions. The ongoing exploration of ST1 recombinant protein offers promising insights into the development of novel therapeutics that can improve clinical outcomes across various medical challenges.
